Chinese consensus on the use of antiarrhythmic drugs for rhythm control in atrial fibrillation / 中华内科杂志
Chinese Journal of Internal Medicine
; (12): 343-355, 2023.
Article
in Zh
| WPRIM
| ID: wpr-985932
Responsible library:
WPRO
ABSTRACT
Rhythm control is crucial part of comprehensive management of atrial fibrillation (AF). Rhythm control can reduce the burden of AF effectively, reduce symptoms, and improve the prognosis in early AF. Antiarrhythmic drugs (AADs) are the first-line treatment for rhythm-control strategies. This consensus focuses on the principle of rhythm control in AF, the characteristics of AADs, and the medication recommendations for patients in different populations suffering from AF. Hence, this consensus aims to support clinical decision-making for AF therapy.
Full text:
1
Database:
WPRIM
Main subject:
Atrial Fibrillation
/
China
/
Consensus
/
Anti-Arrhythmia Agents
Limits:
Humans
Country/Region as subject:
Asia
Language:
Zh
Journal:
Chinese Journal of Internal Medicine
Year:
2023
Document type:
Article